Interventional cardiology is a branch of cardiology that deals specifically with the catheter based treatment of structural heart diseases. Andreas Gruentzig is considered the father of interventional cardiology after the development of angioplasty by interventional radiologist Charles Dotter.
A coronary stent is a tube-shaped device placed in the coronary arteries that supply blood to the heart, to keep the arteries open in patients suffering from coronary heart disease. The vast majority of stents used in modern interventional cardiology are drug-eluting stents (DES). They are used in a medical procedure called percutaneous coronary intervention (PCI). Coronary stents are divided into two broad types: drug-eluting and bare metal stents. As of 2023, drug-eluting stents were used in more than 90% of all PCI procedures. Stents reduce angina and have been shown to improve survival and decrease adverse events after a patient has suffered a heart attack—medically termed an acute myocardial infarction.
Valentín Fuster Carulla, 1st Marquess of Fuster is a Spanish cardiologist and aristocrat.
Annapoorna Kini is an American cardiologist. She is Professor of Cardiology and Interventional Director of Structural Heart Program at Mount Sinai School of Medicine in New York City.
F. Mason Sones, Jr. was an American physician whose pioneering work in cardiac catheterization was instrumental in the development of both coronary artery bypass surgery and interventional cardiology.
Purshotam Lal is an Indian cardiologist and chairman and director of Interventional Cardiology of the Metro Group of Hospitals. He has been awarded the Padma Vibhushan (2009), Padma Bhushan (2003),Dr. B. C. Roy Award (2004), and Honorary Degree of Doctor of Science (Medicine) (2022), He specializes in non-surgical closure of heart holes (ASD/VSD), non-surgical replacement of valves, and treatment of multiple sclerosis.
Prof. (Dr.) Tejas Madhusudan Patel, is a cardiologist from Ahmedabad, India, and Chairman and Chief Interventional Cardiologist at Apex Heart Institute, Ahmedabad. Dr. Patel, a recipient of the Dr. B. C. Roy Award, the highest Indian medical honor, was honored by the Government of India in 2015 with the Padma Shri, the fourth highest Indian civilian award. In 2024, he was awarded the Padma Bhushan, one of India's highest civilian honors, for his outstanding contributions to cardiology.
The Zucker School of Medicine is the medical school of Hofstra University in the town of Hempstead on Long Island, in the U.S. state of New York. The academic institution was established in 2008 by Hofstra University and the North Shore-LIJ Hospital system which was rebranded as Northwell Health in 2015. The Zucker School of Medicine enrolls 99 students each year and offers an MD and PhD. It also offers a joint MD—PhD degree; joint MD—MPH ; joint MD—MBA ; and joint MD—OMS. It also offers a dual-degree "4+4" program comprising an undergraduate degree followed by automatic matriculation to the School of Medicine.
Alice K. Jacobs is a professor at the Boston University Chobanian & Avedisian School of Medicine who specializes in interventional cardiology, coronary revascularization, and sex-based differences in cardiovascular disease.
Ulf Landmesser is a German specialist for cardiology and internal medicine. He is professor at the Institute for Health Research in Berlin and Head of the Medical Clinic of Cardiology at the Charité in Berlin. Landmesser is known for his work on coronary interventions and modern methods of catheter-based heart valve therapy.
Daljeet Singh Gambhir is an Indian cardiologist, medical academic, researcher and inventor and the Group Director of Cardiology at Kailash Group of Hospitals and Heart Institute, Noida. He is the inventor of Infinnium Paclitaxel-Eluting Stent, a reportedly cheaper drug-eluting stent which he first presented at the EuroPCR meeting held in Paris in 2003. A fellow of the National Academy of Medical Sciences and an honorary fellow of the Indian College of Cardiology, he is reported to have performed over 10,000 coronary interventions. The Government of India awarded him the fourth highest civilian honour of the Padma Shri, in 2016, for his contributions to medicine.
Donald S. Baim was a researcher and clinician in the field of interventional cardiology. Baim's primary research focused on coronary blood flow, catheter intervention in heart disease, and congestive heart failure. His work helped to shift the use of catheters from a purely diagnostic tool to a therapeutic tool. After receiving a medical degree from Yale and initial medical training, residency and a fellowship at Stanford University Medical Center, Baim spent the bulk of his career at Beth Israel Hospital and at the Brigham and Women's Hospital in Boston. In 1993, Baim founded the Beth Israel Hospital's Cardiovascular Data Analysis Center (CDAC) -- later to be named Harvard Clinical Research Institute (HCRI). Baim died of cancer in November 2009. In October 2016, HCRI changed its name to the Baim Institute for Clinical Research.
Shahbudin Rahimtoola was a cardiologist based in Los Angeles, United States. He served as a Distinguished Professor at the Keck School of Medicine, University of Southern California. Rahimtoola was credited for his contribution to two clinical syndromes namely the hibernating myocardium and 'prosthetic valve-mismatch'.
Karina W. Davidson is senior vice president of research at Northwell Health and director of the Institute of Health System Science at the Feinstein Institutes of Medical Research. She was previously vice-dean of organizational effectiveness and executive director of the Center for Behavioral Cardiovascular Health at Columbia University Medical Center. She was also Chief Academic Officer at NewYork-Presbyterian Hospital in New York City.
Samin K. Sharma is an American philanthropist of Indian descent and an interventional cardiologist who co-founded the Eternal Heart Care Centre and Research Institute in Jaipur (EHCC). Sharma has served on New York State’s Cardiac Advisory Board since 2004. As of 2021, he is Senior Vice-President, Operations & Quality at The Mount Sinai Hospital in New York and runs the Dr. Samin K. Sharma Family Foundation Cardiac Catheterization Laboratory. As of 2018, he is Chairman Board of Trustees, Association of Indians in America (AIA). As of 2022, he has been an investigator on 86 grants and multi-center trials and authored 486 peer-reviewed articles that have been cited 21,734 times.
Richard Gorlin was an American cardiologist known for his contributions to the fields of valvular heart disease, coronary artery disease and cardiac catheterization, digitalis and vasodilators in congestive heart failure, and thrombolysis in myocardial infarctions. Along with his father, developed the Gorlin formula used to calculate valve areas in aortic valve stenosis and mitral valve stenosis.
Wael Fahed Al-Husami is a Jordanian cardiologist and interventional cardiologist, scientist and medical educator at Tufts University and a faculty member at Brown University’s Alpert Medical School, and a faculty Member at BIDMC Disaster Medicine Fellowship - Harvard Medical School. Wael Al-Husami is also a visiting professor of Medicine at the Royal College of Surgeons in Ireland.
Jason C. Kovacic is an Australian-born cardiologist and physician-scientist; the Robert Graham Chair and Professor of Medicine, University of New South Wales; Executive Director of the Victor Chang Cardiac Research Institute in Sydney, Australia; and Professor of Medicine (Cardiology) at the Icahn School of Medicine at Mount Sinai, New York.
Sanjay Rajagopalan is the Herman Hellerstein Professor of Medicine and Chief Scientific and Medical Officer at the Harrington Heart and Vascular Institute, University Hospitals and Professor Medicine at Case Western Reserve University (CWRU) in Cleveland, Ohio. He holds secondary appointments in the Case Western Reserve University Departments of Physiology, Radiology and Biomedical Engineering. Much of his research has been on using technology to guide the detection and treatment of heart disease and more recently on the impact of environmental exposures and climate change on cardiovascular health.
Deepak L. Bhatt is a US interventional cardiologist, researcher, and educator. He is known for novel clinical trials in cardiovascular prevention, intervention, and heart failure. As of 2024, he is the director of Mount Sinai Fuster Heart Hospital in New York City and the Dr. Valentin Fuster Professor of Cardiovascular Medicine at the Icahn School of Medicine at Mount Sinai Health System. Prior, he served as the executive director of Interventional Cardiovascular programs at Brigham and Women’s Hospital Heart and Vascular Center and a professor of medicine at Harvard Medical School. He was given the American College of Cardiology's Distinguished Mentor Award in 2018, and in 2019, the American Heart Association presented him with its Distinguished Scientist award. As of 2024, Google Scholar reports that he has been cited 279,202 times, has an h-index of 194, and an i10-index of 1,249.
